NEW YORK – The European Commission (EC) on Monday granted marketing authorization to AbbVie's Elahere (mirvetuximab soravtansine) as a new therapy option for previously treated patients with folate ...

Roche (RHHBY) announced that it has received CE Mark for its Ventana FOLR1 RxDx Assay. This is the first immunohistochemistry, or IHC, ...

Swiss drug major Roche Group (RHHBY) announced Monday that it has received CE Mark for its VENTANA FOLR1 (FOLR1-2.1) RxDx Assay, ...

AbbVie (NYSE: ABBV) today announced the European Commission (EC) granted marketing authorization for ELAHERE® (mirvetuximab soravtansine) for the treatment of adult patients with folate receptor-alpha ...

The US FDA has approved Vyloy in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of advanced gastric or gastroesophageal junction cancer.

The FDA continues to approve new drugs and expand indications for others at a rapid pace. Here’s a summary of what happened ...

This study highlights the clinical utility of the PredicineCARE™ liquid biopsy assay in Roche’s pivotal INAVO120 Phase 3 clinical trial of Inavolisib (Itovebi), which targets patients with ...

This adds value to multiplex assays, proving to be a positive market force. Key Findings from the Market Report The global multiplex assay market is segmented based on product type, the technology ...

Under this agreement, the Bladder CARE™ Assay will be covered by insurance, enhancing access for patients. This strategic collaboration aims to streamline cancer diagnostics in Switzerland ...

The 2024 deep drilling program has delivered further evidence of a very extensive laterally oriented deeper copper horizon that covers an area of more than 10 square kilometres ("km 2")and remains ...

Gold Geochemistry and Trapper Target Location Map. Table 1. Select Mineralized Intervals for the Trapper Target Drilling. All assay values are uncut weighted averages and intervals reflect drilled ...

The UltraQual Multiplex PCR Assay screens simultaneously for the HCV, HIV-1, HIV-2 and HBV viruses in a single sample. “This next-generation technology offers the international biopharmaceutical ...